Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A M MacLeod

Showing results (131-140 of 197) with videos related to

Pageof 20
Sort By:
Nephron|January 1, 1992
Establishing a normal baseline for immunohistochemical studies of the kidneyP Roy-Chaudhury, M C Jones, A M MacLeod, et al.
Pathology|October 1, 1993
An immunohistological study of epidermal growth factor receptor and neu receptor and neu receptor expression in proliferative glomerulonephritisP Roy-Chaudhury, M C Jones, A M MacLeod, et al.
Transplantation Proceedings|February 1, 1989
Modulation of lymphocytotoxic activity in highly sensitised patients by anti-idiotypic antibodiesA M MacLeod, I A al-Muzairai, A Innes, et al.
Journal of Clinical Pathology|July 1, 1987
Non-cytotoxic antibodies in chronic lymphocytic leukaemiaA M MacLeod, E J Minford, D J King, et al.
Plastic and Reconstructive Surgery|November 1, 1973
Clinical replantation of digitsB M O'Brien, A M MacLeod, G D Miller, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 24, 2001
A default mode of brain functionM E Raichle, A M MacLeod, A Z Snyder, et al.
Journal of Medicinal Chemistry|June 9, 1995
Identification of 3,5-dihydro-2-aryl-1H-pyrazolo[3,4-c]quinoline-1,4(2H)-diones as novel high-affinity glycine site N-methyl-D-aspartate antagonistsA M MacLeod, S Grimwood, C Barton, et al.
The Journal of Pathology|August 1, 1997
Upregulation and co-localization of connexin43 and cellular adhesion molecules in inflammatory renal diseaseG S Hillis, L A Duthie, P A Brown, et al.
Gene|November 12, 1992
Streptomyces lividans glycosylates an exoglucanase (Cex) from Cellulomonas fimiA M MacLeod, N R Gilkes, L Escote-Carlson, et al.
Journal of Medicinal Chemistry|July 9, 1993
N-acyl-L-tryptophan benzyl esters: potent substance P receptor antagonistsA M MacLeod, K J Merchant, M A Cascieri, et al.
Pageof 20

Showing results (131-140 of 197) with videos related to

Sort By:
Pageof 20
Nephron|January 1, 1992
Establishing a normal baseline for immunohistochemical studies of the kidneyP Roy-Chaudhury, M C Jones, A M MacLeod, et al.
Pathology|October 1, 1993
An immunohistological study of epidermal growth factor receptor and neu receptor and neu receptor expression in proliferative glomerulonephritisP Roy-Chaudhury, M C Jones, A M MacLeod, et al.
Transplantation Proceedings|February 1, 1989
Modulation of lymphocytotoxic activity in highly sensitised patients by anti-idiotypic antibodiesA M MacLeod, I A al-Muzairai, A Innes, et al.
Journal of Clinical Pathology|July 1, 1987
Non-cytotoxic antibodies in chronic lymphocytic leukaemiaA M MacLeod, E J Minford, D J King, et al.
Plastic and Reconstructive Surgery|November 1, 1973
Clinical replantation of digitsB M O'Brien, A M MacLeod, G D Miller, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 24, 2001
A default mode of brain functionM E Raichle, A M MacLeod, A Z Snyder, et al.
Journal of Medicinal Chemistry|June 9, 1995
Identification of 3,5-dihydro-2-aryl-1H-pyrazolo[3,4-c]quinoline-1,4(2H)-diones as novel high-affinity glycine site N-methyl-D-aspartate antagonistsA M MacLeod, S Grimwood, C Barton, et al.
The Journal of Pathology|August 1, 1997
Upregulation and co-localization of connexin43 and cellular adhesion molecules in inflammatory renal diseaseG S Hillis, L A Duthie, P A Brown, et al.
Gene|November 12, 1992
Streptomyces lividans glycosylates an exoglucanase (Cex) from Cellulomonas fimiA M MacLeod, N R Gilkes, L Escote-Carlson, et al.
Journal of Medicinal Chemistry|July 9, 1993
N-acyl-L-tryptophan benzyl esters: potent substance P receptor antagonistsA M MacLeod, K J Merchant, M A Cascieri, et al.
Pageof 20